The Thomä lab focuses on the structure and function of macromolecular machines at the interface of chromatin, ubiquitin biology and cancer. Recent work from the laboratory illustrated how transcription factor operate in the context of chromatin, and how endogenous and synthetic small molecules drive the degradation of transcription factors and other cellular proteins by leveraging the ubiquitin proteasome system.